Jovanović Natasa, Bouchard Andréanne, Hofland Gerard W, Witkamp Geert-Jan, Crommelin Daan J A, Jiskoot Wim
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands.
Eur J Pharm Biopharm. 2008 Feb;68(2):183-90. doi: 10.1016/j.ejpb.2007.05.001. Epub 2007 May 10.
The aim of this study was to stabilize human serum immunoglobulin G (IgG) by a supercritical fluid (SCF) drying process. Solutions containing IgG (20mg/ml) and trehalose or hydroxypropyl-beta-cyclodextrin in a 1:4 (w/w) ratio were sprayed into a SCF phase consisting of CO(2) and ethanol at 100bar and 37 degrees C. Initially, a set of drying conditions previously developed to successfully stabilize lysozyme and myogobin formulations was used [N. Jovanović, A. Bouchard, G.W. Hofland, G.J. Witkamp, D.J.A. Crommelin, W. Jiskoot, Eur. J. Pharm. Sci. 27 (2006) 336-345]. Dried formulations were analyzed by Karl Fisher titration, scanning electron microscopy, X-ray powder diffraction, and modulated DSC. Protein structure in the solid-state was studied by FTIR and after reconstitution by UV/Vis, circular dichroism and fluorescence spectroscopy, GPC and SDS-PAGE. When IgG was dried under the above-mentioned conditions, substantial amounts of insoluble aggregates were formed. Addition of buffer helped to reduce the fraction of insoluble material but not of soluble aggregates. Full stabilization could be achieved by adjusting the process conditions: drying without ethanol while keeping the other conditions the same, or drying with ethanol at a temperature below the critical point (20 degrees C). In conclusion, it is possible to stabilize human IgG by SCF drying provided that the formulation and process conditions are tailored to meet the specific requirements of the protein.
本研究的目的是通过超临界流体(SCF)干燥工艺来稳定人血清免疫球蛋白G(IgG)。将含有IgG(20mg/ml)和海藻糖或羟丙基-β-环糊精且比例为1:4(w/w)的溶液喷入由二氧化碳和乙醇组成的超临界流体相中,压力为100bar,温度为37℃。最初,使用了一组先前开发的用于成功稳定溶菌酶和肌红蛋白制剂的干燥条件[N. 约万诺维奇、A. 布沙尔、G.W. 霍夫兰、G.J. 维特坎普、D.J.A. 克罗梅林、W. 吉斯科特,《欧洲药学杂志》27(2006)336 - 345]。通过卡尔费休滴定法、扫描电子显微镜、X射线粉末衍射和调制差示扫描量热法对干燥后的制剂进行分析。通过傅里叶变换红外光谱研究固态下的蛋白质结构,重构后通过紫外/可见光谱、圆二色光谱和荧光光谱、凝胶渗透色谱和十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳进行研究。当IgG在上述条件下干燥时,会形成大量不溶性聚集体。添加缓冲剂有助于减少不溶性物质的比例,但不能减少可溶性聚集体的比例。通过调整工艺条件可以实现完全稳定:在保持其他条件相同的情况下不使用乙醇进行干燥,或者在低于临界点(20℃)的温度下使用乙醇进行干燥。总之,只要根据蛋白质的特定要求调整制剂和工艺条件,就有可能通过超临界流体干燥来稳定人IgG。